One-year COVID-19 outcomes on the oncology care patient pathway: Results of a French descriptive, cross-sectional comprehensive study (ONCOCARE-COV).

Fiche publication

Date publication

mai 2022

Journal

Cancer medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier , Dr DALSTEIN Véronique , Dr GARBAR Christian , Pr MERROUCHE Yacine , Dr BOULAGNON-ROMBI Camille , Dr DEBREUVE-THERESETTE Adeline

Tous les auteurs :
Laurent L, Brugel M, Carlier C, Clere F, Bertrand A, Botsen D, Boulagnon-Rombi C, Dalstein V, Debreuve-Theresette A, Deguelte S, Garbar C, Mahmoudi R, Marechal A, Morland D, Rey JB, Schvartz C, Vallet C, Merrouche Y, Slimano F, Bouché O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35593199

Résumé

The COVID-19 pandemic led to a widely documented disruption in cancer care pathway. Since a resurgence of the pandemic was expected after the first lockdown in France, the global impact on the cancer care pathway over the year 2020 was investigated.